# Blue Lake Biotechnology, Inc. — Form D/A

Blue Lake Biotechnology, Inc. of ATHENS, GA, a company, filed a Form D amendment with the SEC on 2020-11-06. The offering totals $8.8M, of which $8.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-11-06
- Form: D/A
- Accession: 0001802857-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.8M
- Amount sold: $8.8M
- Investors: 1
- Date of first sale: 2019-12-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-361848

## Issuer

- Name: Blue Lake Biotechnology, Inc.
- CIK: 0001802857
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 111 RIVERBEND ROAD, ATHENS, GA, 30602
- Phone: 706-201-8820

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Jixiang An | Director | Athens, GA |
| Biao He | Director | San Francisco, CA |
| Biao He | Executive Officer | San Francisco, CA |
| Biao He | Promoter | San Francisco, CA |
| Yuan Lin | Director | Athens, GA |
| Fred Quinn | Director | Athens, GA |
| Ji Ma | Director | Athens, GA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-11-08](https://search.stillhousedata.com/formd/0001802857-22-000001) | D | $10.0M | $10.0M |
| [2020-03-03](https://search.stillhousedata.com/formd/0001802857-20-000001) | D | $6.0M | $6.0M |

## More

- [CIK 1802857 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1802857&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001802857-20-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.